// App-Quantinova.ai

: Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used

Researchers

Presenter

  • Julia Carlens

Principal Investigators

  • Matthias Griese

  • Andrew Bush

  • Annick Clement

  • Steve Cunningham

  • Meike Hengst

  • Nural Kiper

  • Anastasiia Korotkaia

  • Katarzyna Krenke

  • Joanna Lange

  • Elias Seidl

  • Deborah Snijders

  • Martin Wetzke

  • Nicolaus Schwerk

Medical Centers

  • Paediatric Pulmonology, Allergy and Neonatology, Hanover Medical School, Hanover, Germany

  • Childrens Hospital Ludwigs-Maximilians-University, Munchen, Germany

  • Departments of Paediatrics and Paediatric Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, United Kingdom

  • Department of Pediatric Pulmonology National Reference Center for Rare Lung Diseases University Pierre et Marie Curie Trousseau Hospital, Paris, France

  • Department of Respiratory and Sleep Medicine, Royal Hospital for Sick Children, Edinburgh, United Kingdom

  • Department of Pediatric Pulmonology Ihsan Dogramaci Children's Hospital, Hacettepe University Faculty of Medicine, Ankara, Turkey

  • Medical University of Warsaw, Pediatric Pneumonology and Allergy, Warsaw, Poland

  • Department of Women and Children Health, University Hospital of Padova, Padova, Italy

Locations

  • Germany

  • United Kingdom

  • France

  • Turkey

  • Poland

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved